Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2012

Dec 12, 2012

30198_dirs_2012-12-12_8955c016-f915-4165-89d4-cd75b74f0995.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-12-10

Reporting Person: ROPER JESS (VP, CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-10 Common Stock S 714 $13.8315 Disposed 58719 Direct
2012-12-10 Common Stock S 3001 $13.843 Disposed 55718 Direct
2012-12-10 Common Stock S 5000 $13.85 Disposed 0 Indirect

Footnotes

F1: Included in this number are 38,501 unvested restricted stock units, 12,876 of which were granted on March 8, 2011 and shall vest through March 8, 2014, and 25,625 of which were granted on March 8, 2012 and shall vest through March 8, 2015.